David Patience's Insider Trades & SAST Disclosures
David Patience's most recent trade in Accelerate Diagnostics Inc was a trade of 20,000 Employee Restricted Stock Units done . Disclosure was reported to the exchange on April 1, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern David Patience.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 20,000 | 30,000 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2025 | 20,000 | 71,384 (0%) | 0% | 0 | Common Stock | |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.71 per share. | 01 Apr 2025 | 6,816 | 64,568 (0%) | 0% | 0.7 | 4,839 | Common Stock |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 1,500 | 51,919 (0%) | 0% | 0 | Common Stock | |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2025 | 1,500 | 0 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 1.09 per share. | 26 Feb 2025 | 535 | 51,384 (0%) | 0% | 1.1 | 583 | Common Stock |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2024 | 120,000 | 120,000 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2024 | 37,468 | 63,715 (0%) | 0% | 0 | Common Stock | |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Apr 2024 | 37,468 | 0 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.87 per share. | 09 Apr 2024 | 13,296 | 50,419 (0%) | 0% | 0.9 | 11,568 | Common Stock |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Mar 2024 | 37,468 | 37,468 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 1,000 | 1,500 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 26 Feb 2024 | 1,000 | 26,597 (0%) | 0% | 0 | Common Stock | |
| Accelerate Diagnostics Inc | Patience David | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.96 per share. | 26 Feb 2024 | 350 | 26,247 (0%) | 0% | 1.0 | 336 | Common Stock |
| Accelerate Diagnostics Inc | Patience David | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 16,666 | 25,597 (0%) | 0% | - | Common Stock | |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2024 | 16,666 | 16,666 | - | - | Common Stock Warrants (right to buy) | |
| Accelerate Diagnostics Inc | Patience David | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 331 | 0 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Dec 2023 | 331 | 9,028 (0%) | 0% | 0 | Common Stock | |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 4.39 per share. | 13 Dec 2023 | 97 | 8,931 (0%) | 0% | 4.4 | 426 | Common Stock |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2023 | 331 | 1,324 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Aug 2023 | 331 | 8,088 (0%) | 0% | 0 | Common Stock | |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.80 per share. | 13 Aug 2023 | 95 | 7,993 (0%) | 0% | 6.8 | 646 | Common Stock |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jul 2023 | 330 | 7,849 (0%) | 0% | 0 | Common Stock | |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jul 2023 | 330 | 1,655 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 6.90 per share. | 13 Jul 2023 | 92 | 7,757 (0%) | 0% | 6.9 | 635 | Common Stock |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2023 | 611,842 | 611,842 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2023 | 3,309 | 19,853 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Jun 2023 | 3,309 | 76,479 (0%) | 0% | 0 | Common Stock | |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.90 per share. | 13 Jun 2023 | 1,287 | 75,192 (0%) | 0% | 0.9 | 1,158 | Common Stock |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 3,309 | 23,162 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2023 | 3,309 | 74,392 (0%) | 0% | 0 | Common Stock | |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.69 per share. | 15 May 2023 | 1,222 | 73,170 (0%) | 0% | 0.7 | 843 | Common Stock |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2023 | 3,309 | 72,230 (0%) | 0% | 0 | Common Stock | |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Apr 2023 | 3,309 | 26,471 | - | - | Employee Restricted Stock Units | |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 0.65 per share. | 13 Apr 2023 | 1,147 | 71,083 (0%) | 0% | 0.7 | 746 | Common Stock |
| Accelerate Diagnostics Inc | David Patience | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2023 | 500,000 | 500,000 | - | - | Employee Restricted Stock Units |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges